Cardinal Health, Inc. (NYSE:CAH) Receives Average Recommendation of “Moderate Buy” from Analysts

Cardinal Health, Inc. (NYSE:CAH) has been given a consensus recommendation of “Moderate Buy” by the eleven brokerages that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $103.07.

A number of analysts have recently issued reports on the company. UBS Group lifted their price target on Cardinal Health from $122.00 to $125.00 and gave the stock a “buy” rating in a research note on Monday, February 5th. SVB Leerink assumed coverage on Cardinal Health in a research note on Monday, February 26th. They issued an “outperform” rating and a $125.00 price target on the stock. Leerink Partnrs reaffirmed an “outperform” rating on shares of Cardinal Health in a research note on Monday, February 26th. Barclays assumed coverage on Cardinal Health in a research note on Wednesday, January 3rd. They issued an “overweight” rating and a $117.00 price target on the stock. Finally, StockNews.com lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Wednesday.

Cardinal Health Price Performance

Cardinal Health stock opened at $103.20 on Monday. The stock has a market capitalization of $25.10 billion, a PE ratio of 40.63, a price-to-earnings-growth ratio of 1.00 and a beta of 0.68. Cardinal Health has a 12 month low of $77.56 and a 12 month high of $116.04. The business has a 50 day simple moving average of $109.51 and a 200-day simple moving average of $104.67.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, February 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.56 by $0.26. The business had revenue of $57.45 billion during the quarter, compared to analysts’ expectations of $57.02 billion. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. The business’s revenue was up 11.6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.32 earnings per share. On average, equities research analysts anticipate that Cardinal Health will post 7.28 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were paid a $0.5006 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.94%. The ex-dividend date was Thursday, March 28th. Cardinal Health’s dividend payout ratio (DPR) is presently 78.74%.

Hedge Funds Weigh In On Cardinal Health

Large investors have recently modified their holdings of the business. Clearstead Trust LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at $25,000. Raleigh Capital Management Inc. raised its holdings in shares of Cardinal Health by 4,466.7% in the 4th quarter. Raleigh Capital Management Inc. now owns 274 shares of the company’s stock valued at $28,000 after buying an additional 268 shares during the period. YHB Investment Advisors Inc. purchased a new stake in shares of Cardinal Health in the 1st quarter valued at $32,000. Cornerstone Planning Group LLC purchased a new stake in shares of Cardinal Health in the 3rd quarter valued at $26,000. Finally, BKM Wealth Management LLC purchased a new stake in shares of Cardinal Health in the 4th quarter valued at $30,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.